MedTrace Logo

Human Beta-2 Adrenergic Stimulation and Muscle Glucose Uptake

NCT03800290 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2022-12-01

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of two weeks clenbuterol/placebo supplementation on skeletal muscle glucose disposal in healthy male volunteers.

Conditions

  • Healthy

Interventions

DRUG

Clenbuterol Hydrochloride

Daily ingestion of clenbuterol hydrochloride capsules (40 microgram/day) for a total period of 14 days with a wash-out period of 4 weeks.

DRUG

Placebos

Daily ingestion of placebo capsules for a total period of 14 days with a wash-out period of 4 weeks.

Sponsors & Collaborators

  • Maastricht University

    lead OTHER

Principal Investigators

  • Joris Hoeks, PhD · principle investigator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2021-04-23
Completion
2021-04-23

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03800290 on ClinicalTrials.gov